MarginsXMarginsX
Home › Data Desk › Tonix Pharmaceuticals Holding Corp. revenue rises 423.8% in the quarter to Sep 30, 2026

MarginsX Data Desk · Quarterly results · Early-stage clinical trials · At-the-market offering · Customer concentration

Tonix Pharmaceuticals Holding Corp. revenue rises 423.8% in the quarter to Sep 30, 2026

Tonix Pharmaceuticals Holding Corp. (TNXP) filed its 10-Q on Nov 9, 2026, covering the quarter ended Sep 30, 2026. (SEC XBRL company facts, 10-Q, Nov 9, 2026)

By the MarginsX Data Desk, automated. Published November 14, 2026. Data as of November 9, 2026.

Bar chart of Tonix Pharmaceuticals Holding Corp.'s quarterly revenue from Dec 31, 2024 to Sep 30, 2026, the latest quarter highlighted.

Revenue and margins

Revenue was $17.2M, up 423.8% from $3.3M in the same period a year earlier, which ended Sep 30, 2025. (SEC XBRL company facts, 10-Q, Nov 9, 2026)

The net loss was $53.3M. (SEC XBRL company facts, 10-Q, Nov 9, 2026)

Balance sheet

Cash was $162.8M at Sep 30, 2026, against $176.2M at Jun 30, 2026. (SEC XBRL company facts, 10-Q, Nov 9, 2026)

Shares outstanding were 19.4 million, against 17.2 million at Jun 30, 2026, a rise of 13.3%. (SEC XBRL company facts, 10-Q, Nov 9, 2026)

The stock

The Nasdaq screener puts its market value at $63.0M. (Nasdaq stock screener, Nov 13, 2026)

Follow it up

The company's page on MarginsX, with its filings, health check and ownership. (capital.sophiaxt.com/stocks/TNXP)

The filing on SEC EDGAR. (sec.gov)

The filing in the MarginsX reader. (MarginsX reader)

Automated from SEC filings and market data by the MarginsX Data Desk, written by template with no AI. For information only. Not investment advice.

Facts behind this article

FactValueSourceAs of
NameTonix Pharmaceuticals Holding Corp.Source2026-11-13
Revenue change4.238 %Source2026-11-09
Revenue17,234,000 USDSource2026-11-09
Revenue a year earlier3,290,000 USDSource2026-11-09
Period endSep 30, 2026Source2026-11-09
WhoTonix Pharmaceuticals Holding Corp. (TNXP)Source2026-11-13
SymbolTNXPSource2026-11-13
Form10-QSource2026-11-09
FiledNov 9, 2026Source2026-11-09
A year earlier endSep 30, 2025Source2026-11-09
Net loss53,329,000 USDSource2026-11-09
Net income-53,329,000 USDSource2026-11-09
Cash162,793,000 USDSource2026-11-09
Cash prior176,232,000 USDSource2026-08-10
Prior endJun 30, 2026Source2026-08-10
Shares19,431,516 sharesSource2026-11-09
Shares prior17,151,024 sharesSource2026-08-10
Dilution0.133 %Source2026-11-09
Cap62,958,112 USDSource2026-11-13

Sources

Automated from SEC filings and market data. No AI. For information only. Not investment advice.

Discuss in MarginsX More from the Data Desk

More on MarginsX

Companies in this article

Topics

Related Data Desk stories

Every Data Desk article: /desk · RSS